Alicic, Radica Z. http://orcid.org/0000-0002-5437-5700
Cox, Emily J.
Neumiller, Joshua J.
Tuttle, Katherine R. http://orcid.org/0000-0002-2235-0103
Article History
Accepted: 16 October 2020
First Online: 20 November 2020
Competing interests
: K.R.T. has received consulting fees for diabetes and CKD from Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Gilead, Goldfinch Bio, Novo Nordisk and Bayer. J.J.N. has received consulting fees from Novo Nordisk. R.Z.A. has received consulting fees from Boehringer Ingelheim. E.J.C. declares no competing interests.